James’s group studies how the microbiome causes chronic diseases such as cancer, and he is developing novel methodologies for engineering the microbiome as a cancer therapy. He is also currently funded by CRUK, DASA, Horizon 2020 and the EPSRC to perform translational research into a diverse set of research themes such as surgical artificial intelligence, augmented reality, and robotics. James has published over 170 peer reviewed papers and he currently supervises 6 PhD students. His first book Dark Matter: The new science of the microbiome was published in 2023.
Title: Microbiome and organ
development and oral health in early life.
+44 (0)1332 224502